Obesity Market Will Become More Fragmented

0905 GMT - The obesity market is set to become more complex, with the current duopoly--Novo Nordisk and Eli Lilly--to be weakened, creating several more investment opportunities than currently

WSJJul 15 05:17 ET

Novo Nordisk A/S (NVO) Is Attracting Investor Attention: Here Is What You Should Know

Yahoo Finance09:00 ET

Novo Nordisk's Main Owner Leads $100 Mln Financing of Biotech Firm Asceneuron

By Dominic Chopping Novo Nordisk's owner led a $100 million Series C fundraising in Asceneuron, a biotech company developing therapeutics for neurodegenerative diseases. Novo Holdings, which owns a

WSJ05:01 ET

Novo-Nordisk (NVO.US) is facing congressional scrutiny in the US due to the discontinuation of its long-acting insulin Levemir in the US market.

Two informed sources said that on Tuesday, Democratic Senate staff will meet with executives from Novo Nordisk to discuss the impact of the company's decision to stop selling a long-acting insulin in the United States.

Zhitong Finance04:30 ET

Novo Holdings Leads $100 Million Series C Financing of Asceneuron to Advance Groundbreaking Therapy for Alzheimer's Disease

COPENHAGEN, Denmark, July 16, 2024 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announces it led a $100 million Series C Financing in Asceneuron, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a driver of neurodegenerative disease.

PR Newswire03:00 ET

Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'

Sen. Bernie Sanders (I-Vt.) recently expressed his concerns about the high cost of medical care in the United States, highlighting the financial burden it places on patients.

Benzinga21:36 ET